Results Healthcare has advised MSD on the divestment of its Mirabel manufacturing site in Riom France, to Fareva

  • Service: Divestments
  • Sector: Healthcare
  • Sub Sector: CROs & CMOs, Pharma & Biotech
  • Engagement Type: Sell Side
Jan 2021
has divested its Mirabel manufacturing site in Riom, France to

Results Healthcare is delighted to have acted as the exclusive advisor to MSD, a leading global biopharmaceutical company, on the divestment of its Mirabel manufacturing site located in Riom France, to Fareva, one of the world’s leading CDMOs in the pharmaceuticals sector.

The transaction includes the transfer of approximately 350 employees to Fareva and substantial future investment into the site. Fareva expects this investment will enable long-term growth and potential job creation at the site.

This cross-border transaction highlights Results Healthcare’s excellent reputation in the healthcare and life sciences sector and is a testament to its international network.

Sector Related Deals

Jan 2022
has divested its API manufacturing site in Cramlington, UK, to
Nov 2021
has made an investment in
company name confidential
Aug 2021
has been acquired by
an Odyssey Investment Partners-backed company
May 2021
has been acquired by
a Behrman Capital-backed company
May 2021
has formed a strategic alliance with
Mar 2021
has licensed the patents and know-how to its Crystalomics Formulation Technology to
Feb 2021
has been acquired by
Jan 2021
has invested in
Jan 2021
has divested its Ringaskiddy analytics and testing site to